Charles River Laboratories International, Inc. (NYSE: CRL) Stock Analysis & Fundamentals | ScreenerHero

Create free account

CRLCharles River Laboratories International, Inc.

NYSE · US · Healthcare · Diagnostics & Research · criver.com

226.79USD+0.54%Mkt Cap: 10.92B $P/E: —1d ago

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Mode…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Avg

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap10.92B $

Enterprise Value13.84B $

Revenue (TTM)4.03B $

Gross Profit1.32B $

Net Income (TTM)-144.34M $

Revenue/Share81.96 USD

Last Price226.79 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees18.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS1598641074

Valuation

P/E (Trailing)—

P/E (Forward)18.43

PEG0.12

EV/EBITDA15.56

EV/Revenue3.44

P/S2.71

P/B3.71

EPS (TTM)-3.70

EPS (Forward)12.31

52W Range

144.2698% of range228.88

52W High228.88 USD

52W Low144.26 USD

Profitability

Gross Margin32.96%

Oper. Margin15.92%

EBITDA Margin22.09%

Profit Margin-3.59%

ROE-4.56%

ROA-2.02%

Growth

Revenue Growth1.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF737.65M $

CapEx (TTM)219.15M $

FCF Margin12.66%

FCF Yield4.67%

Net Debt2.87B $

Net Debt/EBITDA3.23

Balance Sheet

Debt/Equity0.81

Current Ratio1.36

Quick Ratio0.82

Book Value/Sh61.05 USD

Cash/Share3.983 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)215.33 USD

Upside (mean)-5.1%

Target Range135.00 USD – 265.00 USD

$135.00-5.1% to mean$265.00

# Analysts15

Ownership

Shares Out.48.17M

Float47.58M

Insiders0.64%

Institutions123.40%

Short Interest

Short Ratio4.1d

Short % Float8.66%

Short % Out.7.50%

Shares Short3.61M

Short (prev mo.)3.63M

Technical

SMA 50177.72 (+27.6%)

SMA 200179.33 (+26.5%)

Beta1.45

S&P 52W Chg20.05%

Avg Vol (30d)679.92K

Avg Vol (10d)985.95K

Technical Indicators

RSI (14)77.2

MACD11.7166

MACD Signal7.5911

MACD Hist.+4.1255

BB Upper223.34 USD

BB Middle192.53 USD

BB Lower161.71 USD

BB Width32.01%

ATR (14)8.221 USD

Vol Ratio (20d)1.43x